BIG
KNSA icon

Brooklyn Investment Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Brooklyn Investment Group’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$443K Sell
9,208
-2,760
-23% -$122K 0.01% 1122
2025
Q4 		$491K Buy
+11,968
New +$480K 0.02% 672
2025
Q3 		– Sell
-1,163
Closed -$32.2K – 1752
2025
Q2 		$32.2K Buy
1,163
+1,022
+725% +$26K ﹤0.01% 1592
2025
Q1 		$3.13K Buy
+141
New +$2.9K ﹤0.01% 2000

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Brooklyn Investment Group's KNSA Position: Q1 2026 in Review

Brooklyn Investment Group reduced its Kiniksa Pharmaceuticals (KNSA) stake by 23% in Q1 2026, selling an estimated $122K and leaving 9,208 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #1122.

Brooklyn Investment Group first reported a position in KNSA in Q1 2025 and has held it in 4 quarters since. The position peaked at $491K in Q4 2025. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Brooklyn Investment Group held 9,208 shares of Kiniksa Pharmaceuticals worth $443K as of Q1 2026.
  • Brooklyn Investment Group sold 2,760 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $122K.
  • Kiniksa Pharmaceuticals made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1122 holding.
  • Brooklyn Investment Group first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • Brooklyn Investment Group's Kiniksa Pharmaceuticals position peaked at $491K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.